Hancock Whitney’s BioTelemetry, Inc. BEAT Stock Holding History

Hancock Whitney’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-5,064	Closed	-$365K	–	844
2020 Q4	$365K	Sell	5,064 -134	-3%	-$7.01K	0.01%	611
2020 Q3	$237K	Sell	5,198 -89	-2%	-$3.72K	0.01%	681
2020 Q2	$239K	Buy	+5,287	New	+$237K	0.01%	674

Other funds holding BEAT

LCM

Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

Hancock Whitney's BEAT Position: Q1 2021 in Review

Hancock Whitney sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 5,064 shares — an estimated $365K sold.

Hancock Whitney first reported a position in BEAT in Q2 2020 and held it in 3 quarters. The position peaked at $365K in Q4 2020. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

Hancock Whitney reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
Hancock Whitney sold 5,064 BioTelemetry, Inc. shares in Q1 2021, an estimated $365K.
Hancock Whitney first reported a position in BioTelemetry, Inc. in Q2 2020 and held it in 3 quarters.
Hancock Whitney's BioTelemetry, Inc. position peaked at $365K in Q4 2020.
1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on Hancock Whitney's 13F filing for Q1 2021, filed 14 May 2021.